ChiCTR1800014778 版本V1.1 版本创建时间2023/04/03 15:50:28 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR1800014778 

最近更新日期:

Date of Last Refreshed on:

2018-02-11 07:34:42 

注册时间:

Date of Registration:

2018-02-02 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

加速康复外科对结直肠癌老年患者的临床结局影响研究

Public title:

The impact of enhanced recovery after surgery on the clinical outcomes of elderly patients with colorectal cancer

注册题目简写:

English Acronym:

研究课题的正式科学名称:

加速康复外科在结直肠老年患者中的应用

Scientific title:

The application of enhanced recovery after surgery in elderly patients with colorectal cancer

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

赵资文 

研究负责人:

王东升 

Applicant:

Ziwen Zhao 

Study leader:

Dongseng Wang 

申请注册联系人电话:

Applicant telephone:

+86 18769725038

研究负责人电话:

Study leader's telephone:

+86 17660447335

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zhaoziwen89@163.com

研究负责人电子邮件:

Study leader's E-mail:

707643289@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

山东省青岛市黄岛开发区五台山路1677号

研究负责人通讯地址:

山东省青岛市黄岛开发区五台山路1677号

Applicant address:

1677 Wutaishan Road, Huangdao Development Zone, Qingdao, Shandong, China

Study leader's address:

1677 Wutaishan Road, Huangdao Development Zone, Qingdao, Shandong, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

青岛大学附属医院

Applicant's institution:

Affiliated Hospital of Qiingdao University

研究负责人所在单位:

青岛大学附属医院

Affiliation of the Leader:

Affiliated Hospital of Qiingdao University

是否获伦理委员会批准:

否/No

Approved by ethic committee:

No

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Name of the ethic committee:

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

青岛大学附属医院

Primary sponsor:

Affiliated Hospital of Qiingdao University

研究实施负责(组长)单位地址:

山东省青岛市黄岛开发区五台山路1677号

Primary sponsor's address:

1677 Wutaishan Road, Huangdao Development Zone, Qingdao, Shandong, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

山东

市(区县):

青岛

Country:

China

Province:

Shandong

City:

Qingdao

单位(医院):

青岛大学附属医院

具体地址:

山东省青岛市黄岛开发区五台山路1677号

Institution
hospital:

Affiliated Hospital of Qingdao University

Address:

1677 Wutaishan Road, Huangdao Development Zone, Qingdao, Shandong, China

经费或物资来源:

青岛大学附属医院

Source(s) of funding:

Affiliated Hospital of Qiingdao University

Target disease:

colorectal cancer

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

系统分析加速康复外科对结直肠老年患者的临床影响。  

Objectives of Study:

Systematic analysis of the clinical effect of surgery on elderly patients with colorectal cancerenhanced recovery after

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

年龄≥70岁,术前病理证实为结肠癌,能根治性切除,肝肾功能正常

Inclusion criteria

The age ≥ 70 years old, preoperative pathology proved to be colon cancer, radical resection, liver and kidney function is normal

排除标准:

术前存在梗阻、急症手术、联合脏器切除者;合并严重心肺疾病者;术前接受新辅助治疗者;远处转移

Exclusion criteria:

Preoperative obstruction, emergency surgery, combined viscera excision; patients with severe cardiopulmonary disease; preoperative neoadjuvant therapy; distant metastasis

研究实施时间:

Study execute time:

From 2018-04-01 00:00:00 To 2019-03-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2018-04-01 00:00:00 To 2018-09-01 00:00:00  

干预措施:

Interventions:

组别:

试验组

样本量:

70

Group:

Experimental group

Sample size:

干预措施:

加速康复外科

干预措施代码:

Intervention:

Accelerated rehabilitation surgery

Intervention code:

组别:

对照组

样本量:

70

Group:

Control group

Sample size:

干预措施:

空白对照

干预措施代码:

Intervention:

Blank control

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

山东 

市(区县):

黄岛区 

Country:

China 

Province:

Shandong 

City:

 

单位(医院):

青岛大学附属医院 

单位级别:

三级甲等 

Institution
hospital:

Affiliated Hospital of Qiingdao University

Level of the institution:

Tertiary A hospital

测量指标:

Outcomes:

指标中文名:

住院时间

指标类型:

主要指标

Outcome:

length of hospital stay

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 70 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

用SAS软件软件包实现2组等比例随机化,种子数为程序运行日期。SAS统计软件包产生随机数、编号及相应的入组分配方案。并制成总随机分配表。

Randomization Procedure (please state who generates the random number sequence and by what method):

Using SAS software package to achieve two groups of proportional randomization, generate random numbers, numbers, and corresponding allocation plans, a total random distribution table is made.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

通过使用ResMan临床试验公共管理平台

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

using the ResMan Clinical Trial Public Administration Platform

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

纸质CRF收集数据,通过人工录入,把数据存入数据库。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Using paper CRF to collect data,the data is logged into the database via manual imput.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2018-02-04 20:47:34